ANDEXANET ALFA
Approved November 2018 with restriction to Neurosurgery and Emergency Medicine for AC reversal for life-threatening ICH related to apixaban or rivaroxaban.
Approved November 2018 with restriction to Neurosurgery and Emergency Medicine for AC reversal for life-threatening ICH related to apixaban or rivaroxaban.